627
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Sertraline use during pregnancy and effect on fetal cardiac function

, , , &
Pages 3631-3638 | Received 25 Mar 2019, Accepted 30 Oct 2019, Published online: 12 Nov 2019

References

  • Miranda JO, Ramalho C, Henriques-Coelho T, et al. Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function. Heart Fail Rev. 2017;22(6):861–877.
  • Mone SM, Gillman MW, Miller TL, et al. Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. Pediatrics. 2004;113(4 Suppl):1058–1069.
  • Forouzan I, Cohen AW, Lindenbaum C, et al. Umbilical artery and ductal blood flow velocities in patients treated with aspirin and prednisone for presence of anticardiolipin antibody. J Ultrasound Med. 1993;12(3):135–138.
  • Räsänen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol. 1995;173(1):20–25.
  • Pratt L, Digiosia J, Swenson JN, et al. Reversible fetal hydrops associated with indomethacin use. Obstet Gynecol. 1997;90(4 Pt 2):676–678.
  • Interrante JD, Ailes EC, Lind JN, et al. Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997–2011. Ann Epidemiol. 2017;27(10):645–653.e2.
  • Mitchell J, Goodman J. Comparative effects of antidepressant medications and untreated major depression on pregnancy outcomes: a systematic review. Arch Womens Ment Health. 2018;21(5):505–516.
  • Jimenez-Solem E, Andersen JT, Petersen M, et al. Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study. PLoS One. 2013;8(4):e63034.
  • Haskell SE, Lo C, Kent ME, et al. Cardiac outcomes after perinatal sertraline exposure in mice. J Cardiovasc Pharmacol. 2017;70(2):119–127.
  • Haskell SE, Hermann GM, Reinking BE, et al. Sertraline exposure leads to small left heart syndrome in adult mice. Pediatr Res. 2013;73(3):286–293.
  • Sadler TW. Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations. Reprod Toxicol. 2011;32(4):484–489.
  • Noorlander CW, Ververs FF, Nikkels PG, et al. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One. 2008;3(7):e2782.
  • Laurent L, Huang C, Ernest SR, et al. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat. Birth Defects Res A Clin Mol Teratol. 2016;106(12):1044–1055.
  • Ansah DA, Reinking BE, Colaizy TT, et al. A prospective study evaluating the effects of SSRI exposure on cardiac size and function in newborns. Neonatology. 2019;115(4):320–327.
  • Chaoui R, Heling KS. Basics of 3D and 4D fetal echocardiography using spatial and temporal image correlation (STIC) software. Ultraschall in Med.. 2006;27(04):340–346.
  • Chaoui R, Hoffmann J, Heling KS. Three-dimensional (3D) and 4D color Doppler fetal echocardiography using spatio-temporal image correlation (STIC). Ultrasound Obstet Gynecol. 2004;23(6):535–545.
  • DeVore GR, Falkensammer P, Sklansky MS, et al. Spatio-temporal image correlation (STIC): new technology for evaluation of the fetal heart. Ultrasound Obstet Gynecol. 2003;22(4):380–387.
  • Pedersen LH, Mogra R, Hyett J. Effect of corticosteroids on cardiac function in growth-restricted fetuses. Ultrasound Obstet Gynecol. 2016;48(2):204–209.
  • Messing B, Gilboa Y, Lipschuetz M, et al. Fetal tricuspid annular plane systolic excursion (f-TAPSE): evaluation of fetal right heart systolic function with conventional M-mode ultrasound and spatiotemporal image correlation (STIC) M-mode. Ultrasound Obstet Gynecol. 2013;42(2):182–188.
  • Godfrey ME, Messing B, Cohen SM, et al. Functional assessment of the fetal heart: a review. Ultrasound Obstet Gynecol. 2012;39(2):131–144.
  • Van Mieghem T, DeKoninck P, Steenhaut P, et al. Methods for prenatal assessment of fetal cardiac function. Prenat Diagn. 2009;29(13):1193–1203.
  • Hernandez-Andrade E, López-Tenorio J, Figueroa-Diesel H, et al. A modified myocardial performance (Tei) index based on the use of valve clicks improves reproducibility of fetal left cardiac function assessment. Ultrasound Obstet Gynecol. 2005;26(3):227–232.
  • Meriki N, Izurieta A, Welsh AW. Fetal left modified myocardial performance index: technical refinements in obtaining pulsed-Doppler waveforms. Ultrasound Obstet Gynecol. 2012;39(4):421–429.
  • Maheshwari P, Henry A, Welsh AW. The fetal modified myocardial performance index: is automation the future? BioMed Res Int. 2015;2015:1.
  • Wang J, Henry A, Welsh AW, et al. Automated fetal cardiac valve movement detection for modified myocardial performance index calculation. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:1063–1066.
  • Hadlock FP, Harrist RB, Sharman RS, et al. Estimation of fetal weight with the use of head, body, and femur measurements – a prospective study. Am J Obstet Gynecol. 1985;151(3):333–337.
  • Paulzen M, Goecke TW, Stickeler E, et al. Sertraline in pregnancy – therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. J Affect Disord. 2017;212:1–6.
  • Pedersen LH. The risks associated with prenatal antidepressant exposure: time for a precision medicine approach. Expert Opin Drug Saf. 2017;16(8):915–921.
  • Mandrioli R, Saracino MA, Ferrari S, et al. HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;836(1–2):116–119.
  • Mao YK, Zhao BW, Wang B. Z-score reference ranges for angular M-mode displacement at 22–40 weeks’ gestation. Fetal Diagn Ther. 2017;41(2):115–126.
  • Fernández Pineda L, Tamariz-Martel Moreno A, Maître Azcárate MJ, et al. Contribution of Doppler atrioventricular flow waves to ventricular filling in the human fetus. Pediatr Cardiol. 2000;21(5):422–428.
  • Van Mieghem T, Hodges R, Jaeggi E, et al. Functional echocardiography in the fetus with non-cardiac disease. Prenat Diagn. 2014;34(1):23–32.
  • De la Calle M, Rodriguez R, Deirós L, et al. Fetal cardiac biometry and function in HIV-infected pregnant women exposed to HAART therapy. Prenat Diagn. 2015;35(5):453–455.
  • García-Otero L, López M, Gómez O, et al. Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling. AIDS. 2016;30(9):1393–1401.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.